MB Biotech innovations Finance - revenue, profit
Financial ratios
EBITDA margin (%)
Enjoy unlimited use
with Freemium unlimitedEBIT margin (%)
Enjoy unlimited use
with Freemium unlimited| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2023 |
|---|
| 0 |
| - |
| 0 |
| 0 |
| - |
| - |
| - |
| 0 |
| 0 |
| 0 |
| 0 |
| 2024 |
|---|
| 9,652 |
| - |
| -1,358 |
| -1,358 |
| - |
| 78.23 |
| -14.07 |
| 642 |
| 5,141 |
| 0 |
| 5,783 |
| 2025 |
|---|
| 543,755 |
| 293,922 |
| 149,902 |
| 126,135 |
| 68,181 |
| 75.09 |
| 23.20 |
| 126,777 |
| 76,363 |
| 0 |
| 203,140 |
Enjoy unlimited use
with Freemium unlimited| 2025 |
|---|
| 543,755 |
| 293,922 |
| 149,902 |
| 126,135 |
| 68,181 |
| 75.09 |
| 23.20 |
| 126,777 |
| 76,363 |
| 0 |
| 203,140 |
Enjoy unlimited use
with Freemium unlimitedTurnover (€)
2025
Turnover (€)
543,755 €5,534 % *
Sales per employee (€)
293,922 €- *
Profit before tax (€)
149,902 €11,138 % *
Net Profit (€)
126,135 €9,388 % *
Profit per employee (€)
68,181 €- *
Total profitability (%)
75.09 %-4.01 % *
Net profitability (%)
23.20 %264.89 % *
Equity (€)
126,777 €19,647 % *
Amounts Payable And Liabilities (€)
76,363 €1,385 % *
Non-current Assets (€)
0 €- *
CurrentAssets (€)
203,140 €3,413 % *
